Russell 2500 Index

Zacks Investment Management Expands ETF Suite with the Launch of SMIZ

Retrieved on: 
Tuesday, October 3, 2023

Zacks Investment Management , a wholly-owned subsidiary of Zacks Investment Research with $15.1 billion in assets under management, on Oct. 3, 2023, announces the launch of its second actively-managed ETF — the Zacks Small and Mid Cap ETF (NYSE Arca: SMIZ).

Key Points: 
  • Zacks Investment Management , a wholly-owned subsidiary of Zacks Investment Research with $15.1 billion in assets under management, on Oct. 3, 2023, announces the launch of its second actively-managed ETF — the Zacks Small and Mid Cap ETF (NYSE Arca: SMIZ).
  • “SMIZ is a testament to Zacks Investment Management’s commitment to create innovative, research-driven investment solutions,” says Salvatore Esposito, Head of ETF Products.
  • SMIZ follows the launch of Zacks Investment Management’s first ETF, the Zacks Earnings Consistent Portfolio ETF (CBOE: ZECP).
  • Zacks Investment Management, Inc. is the advisor to the Zacks Small/Mid-Cap ETF.

HSBC Asset Management Re-Launches US Smaller Companies Fund With RadiantESG

Retrieved on: 
Wednesday, July 6, 2022

HSBC Asset Management (HSBC AM) has launched the HSBC RadiantESG US Smaller Companies Fund.

Key Points: 
  • HSBC Asset Management (HSBC AM) has launched the HSBC RadiantESG US Smaller Companies Fund.
  • RadiantESG Global Investors1 will take over as the new sub-advisor for the fund which will replace the current HSBC Opportunity Fund a small- and mid-cap growth fund.
  • Stefano Michelagnoli, President of the HSBC Funds, commented: We are excited to be partnering with RadiantESG on this fund.
  • For more information, see assetmanagement.us.hsbc.com/
    HSBC Asset Management is the brand name for the asset management businesses of HSBC Group.

Aldeyra Therapeutics Joins the Russell 2000® and Russell 3000® Indexes

Retrieved on: 
Thursday, July 1, 2021

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company developing novel immune-modulating therapies to treat ocular and systemic diseases, today announced that the company was added to the broad-market Russell 3000 Index and the small-cap Russell 2000 Index, effective after the U.S. market opened on June 28, 2021, as part of the 2021 Russell reconstitution.

Key Points: 
  • Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company developing novel immune-modulating therapies to treat ocular and systemic diseases, today announced that the company was added to the broad-market Russell 3000 Index and the small-cap Russell 2000 Index, effective after the U.S. market opened on June 28, 2021, as part of the 2021 Russell reconstitution.
  • The annual reconstitution of the Russell indexes captures the 4,000 largest US stocks as of May 7, 2021 by total market capitalization.
  • The Russell 3000 Index is comprised of the large-cap Russell 1000 Index and the small-cap Russell 2000 Index.
  • FTSE Russell, a leading global index provider, determines membership for the Russell indexes primarily by objective, market-capitalization rankings and style attributes.

MedAvail Added to Russell 2000® and 3000® Indexes

Retrieved on: 
Monday, June 28, 2021

MedAvail Holdings, Inc. (Nasdaq: MDVL) (MedAvail or the Company) a technology-enabled pharmacy company, today announced that it has been added to the Russell 2000 Index and the broad-market Russell 3000 Index effective after the U.S. market opened on June 28, 2021, following the 2021 Russell indexes annual reconstitution.

Key Points: 
  • MedAvail Holdings, Inc. (Nasdaq: MDVL) (MedAvail or the Company) a technology-enabled pharmacy company, today announced that it has been added to the Russell 2000 Index and the broad-market Russell 3000 Index effective after the U.S. market opened on June 28, 2021, following the 2021 Russell indexes annual reconstitution.
  • Membership in the Russell 3000 Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000 Index or small-cap Russell 2000 Index as well as the appropriate growth and value style indexes.
  • FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.
  • For more information on the Russell 3000 Index and the Russell indexes reconstitution, go to the Russell Reconstitution section on the FTSE Russell website .

The Beauty Health Company Joins Russell 3000® and 2000® Indexes

Retrieved on: 
Monday, June 28, 2021

Membership in the US all-cap Russell 3000 Index, which remains in place for one year, automatically includes the Company in the large-cap Russell 1000 Index or the small-cap Russell 2000 Index, as well as the appropriate growth and value style indexes.

Key Points: 
  • Membership in the US all-cap Russell 3000 Index, which remains in place for one year, automatically includes the Company in the large-cap Russell 1000 Index or the small-cap Russell 2000 Index, as well as the appropriate growth and value style indexes.
  • Clint Carnell, BeautyHealth CEO, stated: We are very pleased that BeautyHealth has been added to the Russell 3000 and 2000 Indexes, marking another milestone for the Company in the public markets.
  • The inclusion of our Company in these indexes will further build investor awareness of our story as we continue to transform into a category-creating beauty health company.
  • For more information on the Russell 3000 Index and the Russell indexes reconstitution, go to the Russell Reconstitution section on the FTSE Russell website .

Kulicke & Soffa Added to Membership of Russell 2000® Index and Russell 3000® Index

Retrieved on: 
Monday, June 28, 2021

Membership in the Russell 2000 Index, which remains in place for one year, is based on membership in the broad-market Russell 3000 Index.

Key Points: 
  • Membership in the Russell 2000 Index, which remains in place for one year, is based on membership in the broad-market Russell 3000 Index.
  • Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies.
  • For more information on the Russell 2000 Index and the Russell indexes reconstitution, go to the "Russell Reconstitution" section on the FTSE Russell website.
  • FTSE Russell is focused on index innovation and customer partnership applying the highest industry standards and embracing the IOSCO Principles.

Lineage Cell Therapeutics Joins Russell 3000® and Russell Microcap® Indexes

Retrieved on: 
Monday, June 28, 2021

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today that the Company has been added to both the broad-market Russell 3000 Index as well as the Russell Microcap Index.

Key Points: 
  • Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today that the Company has been added to both the broad-market Russell 3000 Index as well as the Russell Microcap Index.
  • Membership in the Russell Microcap Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes.
  • FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.
  • The information in this announcement about the Russell indexes and FTSE Russell was obtained from FTSE Russell.

MIMEDX Joins Russell 3000® and 2000® Indexes

Retrieved on: 
Monday, June 28, 2021

MARIETTA, Ga., June 28, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (MIMEDX or the Company), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today confirmed that FTSE Russell will add the Companys common stock to its broad-market Russell 3000 and Russell 2000 Indexes effective after the U.S. market opens today, June 28, as part of the 2021 Russell indexes reconstitution.

Key Points: 
  • MARIETTA, Ga., June 28, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (MIMEDX or the Company), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today confirmed that FTSE Russell will add the Companys common stock to its broad-market Russell 3000 and Russell 2000 Indexes effective after the U.S. market opens today, June 28, as part of the 2021 Russell indexes reconstitution.
  • "Inclusion in the Russell 3000 and 2000 Indexes represents another milestone for MIMEDX that will allow the Company to reach a wider audience within the investment community, said Timothy R. Wright, MIMEDX Chief Executive Officer.
  • Russell indexes are part of FTSE Russell, a leading global index provider.
  • For more information on the Russell 3000 and 2000 Indexes and the Russell indexes reconstitution, go to the Russell Reconstitution section on the FTSE Russell website .

Reviva Added to Russell Microcap® Index

Retrieved on: 
Monday, June 28, 2021

FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings, and style attributes.

Key Points: 
  • FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings, and style attributes.
  • Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies.
  • Russell indexes are part of FTSE Russell, a leading global index provider.
  • For more information on the Russell Microcap Index and the Russell indexes reconstitution, go to the Russell Reconstitution section on the FTSE Russell website: https://www.ftserussell.com/resources/russell-reconstitution
    FTSE Russell is a global index leader that provides innovative benchmarking, analytics, and data solutions for investors worldwide.

Clene Added to Membership of Russell 2000® Index

Retrieved on: 
Monday, June 28, 2021

Membership in the Russell 2000 Index, which remains in place for one year, is based on membership in the broad-market Russell 3000 Index.

Key Points: 
  • Membership in the Russell 2000 Index, which remains in place for one year, is based on membership in the broad-market Russell 3000 Index.
  • Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies.
  • Russell indexes are part of FTSE Russell, a leading global index provider.
  • For more information on the Russell 2000 Index and the Russell indexes reconstitution, go to the Russell Reconstitution section on the FTSE Russell website .